Treatment Information

Back

Liver Cancer treatment details. Chemotherapy.

National Cancer Center Hospital, Tokyo, Japan.

Survival: monthsCountry:Japan
Toxiciy Grade:4City/State/Province:Tokyo
Treatments:ChemotherapyHospital:National Cancer Center Hospital
Drugs:Journal:Link
Date:Oct 2009

Description:

Patients:
This phase III study involved 82 hepatocellular carcinoma patients with a median age of 67 years; 85.4% were male.

Treatment:
Patients were treated with the chemotherapy agent zinostatin stimalamer.

Toxicities:
The most severe adverse effects were of grade 4 and included thrombocytopenia. Elevated liver enzymes, fever, and abdominal pain were also reported.

Results:
The median overall survival was 22.3 months.

Correspondence: Dr. Takuji Okusaka; email: [email protected]



Back